Sarepta Therapeutics Inc (SRPT)

Debt-to-capital ratio

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Long-term debt US$ in thousands
Total stockholders’ equity US$ in thousands 1,527,740 1,221,070 1,077,070 961,192 859,337 764,357 741,411 712,749 384,950 430,840 726,457 856,886 928,009 469,528 485,108 535,445 761,759 892,047 1,042,870 1,144,830
Debt-to-capital ratio 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

December 31, 2024 calculation

Debt-to-capital ratio = Long-term debt ÷ (Long-term debt + Total stockholders’ equity)
= $—K ÷ ($—K + $1,527,740K)
= 0.00

Sarepta Therapeutics Inc has consistently maintained a debt-to-capital ratio of 0.00 throughout the period from March 31, 2020, to December 31, 2024. This indicates that the company has had no debt in its capital structure during this time frame. A debt-to-capital ratio of 0.00 implies that the company has been financing its operations and investments solely through equity rather than debt. This can be seen as a positive sign in terms of financial stability and solvency, as it signifies a lower financial risk due to the absence of debt obligations. However, it is essential to consider the overall financial strategy and business context of the company to fully gauge the implications of this ratio.